MiR-103a-3p aggravates renal cell carcinoma by targeting TMEM33

Objective: We investigated the mechanism of miR-103a-3p-mediated renal cell carcinoma (RCC) progression. Methods: The miR-103a-3p expressions were measured in clinical samples and in two RCC cell lines. MiR-103a-3p was inhibited or over-expressed in the 786-0 and U031 cell lines, respectively. Results: We found that miR-103a-3p is closely related to the development of RCC cells. A bioinformatics analysis and a dual-luciferase reporter gene assay revealed that there is a direct interaction between TMEM33 and miR-103a-3p. Moreover, a rescue assay further confirmed that TMEM33 overexpression can attenuate miR-103a-3p-induced RCC cell development. Conclusion: miR-103a-3p exerts a carcinogenic function in RCC by regulating TMEM33, a finding that may provide new insights into the development of prognostic markers and therapeutic targets for RCC.

Automated summary

miR-103a-3p promotes renal cell carcinoma cell progression by regulating TMEM33. This finding may offer new insights into the identification of prognostic markers and therapeutic targets for RCC.